Monoclonal antibodies represent a revolutionary medical advancement, combining immune system functionality with targeted therapeutic applications. The production process of monoclonal antibodies using hybridoma cells involves sophisticated cellular fusion techniques to create precise medical treatments.
• The process begins with combining mouse lymphocytes with tumor cells to create hybridoma cells
• These antibodies demonstrate remarkable versatility in medical applications, from pregnancy testing to cancer treatment
• Modern developments include human-mouse cell combinations to reduce rejection risks
• The technology offers both significant advantages in targeted treatment and faces challenges like production costs
• Multiple therapeutic applications exist, particularly in cancer treatment through various mechanisms